Status of Erythrocyte Sedimentation Rate, Platelet Counts and Serum Phosphate in Patients with Rheumatoid Arthritis in Owerri

In this study, rheumatoid arthritis patients receiving treatment at the Imo State University Medical Centre in Owerri had their erythrocyte sedimentation rate, platelet counts, and serum phosphate levels examined. For the study, a total of sixty (60) people were chosen. At the Imo State University Medical Center in Owerri, they were divided into two groups: thirty (30) for the test group and thirty (30) for the control group. The Westergreen method was used to measure the rate of erythrocyte sedimentation. Using the "blue" ascorbic acid method, the serum phosphate was measured. Additionally, a manual method was used to count the platelets. The test individuals' erythrocyte sedimentation rate (55.85± 14.75 mm/hr) and the control group's (8.00± 2.98 mm/hr) were compared. Test individuals' platelet count (434.20±183.98x109/L) were contrasted with the control group's (179.90±23.27x109/L). The test subjects' serum phosphate (3.58±0.46 mg/dl) were contrasted with the control group's (2.71±0.62 mg/dl). The erythrocyte sedimentation rate for the male test group (44.71±10.81 mm/hr) and female test group (61.85±13.23 mm/hr) were compared. The male test group's platelet count 473.14±129.06x109/L) and female test group's (413.14±209.54x109/L) were compared. Serum phosphate levels in the male test group (3.20±0.35 mg/dl) and the female test group (3.79±0.37 mg/dl) were compared. For both male and female subjects, the test group's mean and standard deviation of erythrocyte sedimentation rate level were higher than those of the test and control groups of rheumatoid subjects, respectively, as were platelet counts and serum phosphate levels